Starling Oncology, Inc. (NASDAQ:STLN), formerly The Oncology Institute, traded up approximately 37.06 percent in pre-market activity to $6.84 versus Wednesday's close of $4.99. The move follows both the company's rebrand, completed earlier this week, and a quarter that beat expectations on multiple fronts.
Trevi Therapeutics, Inc. (NASDAQ:TRVI) traded up approximately 7.03 percent in pre-market activity, near $19.80 versus Wednesday's close of $18.50. The move follows a second quarter net loss of $0.11 per share matching consensus, with no revenue reported given the company's pre-commercial stage.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) traded down approximately 7.61 percent in pre-market activity, near $76.34 versus Wednesday's close of $82.63. The decline is notable given the underlying quarter was strong, with revenue of $266.0 million topping the $260.1 million consensus and adjusted EPS of $2.21 …
VAALCO Energy (NYSE:EGY) shares rose nearly 6% in premarket trading after the company reported second-quarter results showing a sharp swing to profitability. Net income reached $42.4 million, or $0.39 per diluted share, compared with a $93.8 million loss in the first quarter and $8.4 …
Airbnb (NASDAQ:ABNB) shares surged nearly 8% in premarket trading after the company delivered a second-quarter report that beat across every key metric. Revenue grew 17% year-over-year to $3.6 billion, while EPS of $1.37 topped estimates of $1.25 to $1.26. Gross booking value rose 16% …
FIGS (NYSE:FIGS) shares surged more than 23% in premarket trading after the healthcare apparel company posted second-quarter results that topped both revenue and earnings estimates. Net revenue grew 28.8% year-over-year to $196.6 million, compared with consensus of $186.1 million, marking the company's third straight …
President Trump signed a proclamation imposing a 15% tariff and a series of minimum import prices on products made from polysilicon, the raw material used in both semiconductors and solar panels that is primarily produced by China. The action, taken under Section 232 of …
Sweetgreen (NYSE:SG) shares slumped 15% in premarket trading Friday, a day after the company slashed its annual same-store sales guidance as consumers grew wary of fresh produce amid a nationwide cyclosporiasis outbreak. The company now expects same-store sales to decline 7% to 8% for …
Atlassian (NASDAQ:TEAM) delivered fourth quarter total revenue growth of 28 percent to $1.8 billion, with cloud revenue accelerating to $1.2 billion, up 31 percent year over year, and GAAP operating margin reaching 12 percent. The quarter included all-time record deal activity at the $1 …
Globus Medical (NYSE:GMED) reported second quarter revenue of $789.6 million, up 5.9 percent as reported, with base business revenue excluding Nevro growing 8.9 percent as competitive recruiting, robotics pull-through, and recent product launches continued to drive share gains. U.S. spine revenue grew 7.3 percent, …